LEAH KEEL: Open Payments
NPI 1811236789 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$422 in 20 payments from 13 companies in 2025. Trend: 2023 $160 · 2024 $190 · 2025 $422
Food & beverage: $422
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 4 | $92 |
| Alnylam Pharmaceuticals Inc. | 3 | $61 |
| Novo Nordisk Inc | 3 | $55 |
| AngioDynamics, Inc. | 1 | $45 |
| Edwards Lifesciences Corporation | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| Boston Scientific Corporation | 1 | $21 |
| BridgeBio Pharma, Inc. | 1 | $20 |
| CARDIVA MEDICAL, INC. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: AMVUTTRA, Wegovy, ANGIOVAC, SYMPLICITY G3, AURORA EV-ICD MRI SURESCAN, LINQ II, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, CAMZYOS.
Industry payments across AR — which companies pay providers there.
